Rick E. Winningham, CEO of Theravance Biopharma TBPH, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 09/23.

RW

RW

Rick E. Winningham

CEO

Company

Theravance Biopharma TBPH

First filing

23/02/22

Trades

46 trades

Buys / sales

0 / 3

12-month net buying

−$1.7M

Last trade

09/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Jazz PharmaceuticalsJAZZ	Open-market sale	05/22	05/27	2,741 sh	$241.57	$662,143.37	−22.3%
Jazz PharmaceuticalsJAZZ	Open-market sale	25/11/18	25/11/20	5,500 sh	$180.86	$994,730	−38.2%
Jazz PharmaceuticalsJAZZ	Open-market sale	23/08/14	23/08/15	1,241 sh	$138.16	$171,456.56	−10.6%